comparemela.com
Home
Live Updates
X Biopharma Waferi - Breaking News
Pages:
Latest Breaking News On - X biopharma waferi - Page 1 : comparemela.com
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
Press release content from PR Newswire. The AP news staff was not involved in its creation.
United states
New york
Hong kong
Raj mehra
Geddy lee
X biopharma waferi
European medicines agency
Seelos therapeutics inc
Drug administration
Singapore exchange securities trading limited
Ix biopharma ltd
Seelos therapeutics inc nasdaq
Seelos therapeutics
Scientific advice
Complex regional pain syndrome
Licensed products
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
/PRNewswire/ iX Biopharma Ltd (SGX:42C), a specialty pharmaceutical company that develops innovative therapies using its proprietary sublingual drug.
United states
New york
Hong kong
Raj mehra
Geddy lee
X biopharma waferi
European medicines agency
Seelos therapeutics inc
Drug administration
Singapore exchange securities trading limited
Ix biopharma ltd
Seelos therapeutics inc nasdaq
Seelos therapeutics
Scientific advice
Complex regional pain syndrome
Licensed products
iX Biopharma Ltd: iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
iX Biopharma will receive an initial US$9 million upfront payment Eligible for up to US$239 million in development and sales milestone payments Double digit royalties on future product
United states
New york
Hong kong
Raj mehra
Kostenloser wertpapierhandel
Yee chia hsing
Geddy lee
X biopharma waferi
Seelos therapeutics inc
Drug administration
European medicines agency
Singapore exchange securities trading limited
Ix biopharma ltd
Corporate affairs
Seelos therapeutics inc nasdaq
Seelos therapeutics
vimarsana © 2020. All Rights Reserved.